RT Journal Article
SR Electronic
T1 High-throughput extraction of SARS-CoV-2 RNA from nasopharyngeal swabs using solid-phase reverse immobilization beads
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.08.20055731
DO 10.1101/2020.04.08.20055731
A1 Kalikiri, Mahesh K. R.
A1 Hasan, Mohammad Rubayet
A1 Mirza, Faheem
A1 Xaba, Thabisile
A1 Tang, Patrick
A1 Lorenz, Stephan
YR 2020
UL http://medrxiv.org/content/early/2020/04/11/2020.04.08.20055731.abstract
AB The ongoing pandemic of the novel coronavirus, SARS-CoV-2, has led to a global surge in laboratory testing for the virus. The gold standard approach to detecting an active viral infection is the use of RT-qPCR. This approach requires the isolation of viral RNA from respiratory specimens, such as nasopharyngeal swabs.We developed a method using a widely available lysis buffer coupled with solid-phase reverse immobilization (SPRI) beads to extract viral RNA from swabs collected in viral transport medium (VTM) which can be performed manually or on a Hamilton STAR liquid-handling robot. Using a WHO recommended, laboratory-developed RT-qPCR for SARS-CoV-2, we validated this method in a CAP-accredited laboratory, against the IVD-labelled bioMérieux NucliSENS easyMAG automated extraction platform.Our method demonstrates a comparable sensitivity and specificity, making it suitable for large-scale testing and monitoring of suspected COVID-19 cases and health care workers. This is especially important as the world faces critical shortages of viral RNA extraction reagents for the existing commercial extraction systems.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work in this article was solely funded by Sidra Medicine.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data will be made available on request. Supplementary package files to run this method on a Hamilton STAR liquid handler can be found on https://github.com/Sidra-IGS/covid-19 https://github.com/Sidra-IGS/covid-19